Rankings
▼
Calendar
HRTX Q1 2024 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HRTX
Heron Therapeutics, Inc.
$162M
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$35M
+17.1% YoY
Gross Profit
$26M
75.6% margin
Operating Income
-$5M
-13.8% margin
Net Income
-$3M
-9.1% margin
EPS (Diluted)
$-0.02
QoQ Revenue Growth
+1.3%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$218M
Total Liabilities
$252M
Stockholders' Equity
-$34M
Cash & Equivalents
$20M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$35M
$30M
+17.1%
Gross Profit
$26M
$13M
+105.5%
Operating Income
-$5M
-$33M
+85.5%
Net Income
-$3M
-$33M
+90.4%
Revenue Segments
C I N V A N T I
$26M
75%
Z Y N R E L E F
$5M
15%
S U S T O L
$4M
11%
← FY 2024
All Quarters
Q2 2024 →